| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
|
Rentsch, Cyrill A.
|
|
|
5 |
2 |
p. 195-202
|
artikel
|
| 2 |
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
|
Fischer-Valuck, Benjamin W.
|
|
|
5 |
2 |
p. 246-250
|
artikel
|
| 3 |
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial
|
Rini, Brian I.
|
|
|
5 |
2 |
p. 225-234
|
artikel
|
| 4 |
Contents
|
|
|
|
5 |
2 |
p. iii-vi
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
5 |
2 |
p. i-ii
|
artikel
|
| 6 |
Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer
|
Roberts, Morgan E.
|
|
|
5 |
2 |
p. 214-215
|
artikel
|
| 7 |
Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings
|
Lantz, Anna
|
|
|
5 |
2 |
p. 187-194
|
artikel
|
| 8 |
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
|
Labanca, Estefania
|
|
|
5 |
2 |
p. 164-175
|
artikel
|
| 9 |
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
|
Vickers, Andrew J.
|
|
|
5 |
2 |
p. 135-137
|
artikel
|
| 10 |
Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer
|
Taber, Ann
|
|
|
5 |
2 |
p. 203-213
|
artikel
|
| 11 |
Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?
|
Mottet, Nicolas
|
|
|
5 |
2 |
p. 259-260
|
artikel
|
| 12 |
Incidental Prostate Cancer (cT1a–cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines
|
Capitanio, Umberto
|
|
|
5 |
2 |
p. 256-258
|
artikel
|
| 13 |
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non–muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience
|
Contieri, Roberto
|
|
|
5 |
2 |
p. 251-255
|
artikel
|
| 14 |
New Landmarks Towards Reducing the Treatment Burden for Patients with a Postchemotherapy Residual Retroperitoneal Mass from Nonseminomatous Germ-cell Testicular Tumors
|
Nicolai, Nicola
|
|
|
5 |
2 |
p. 244-245
|
artikel
|
| 15 |
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
|
Hannan, Raquibul
|
|
|
5 |
2 |
p. 216-224
|
artikel
|
| 16 |
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer
|
Meijer, Dennie
|
|
|
5 |
2 |
p. 146-152
|
artikel
|
| 17 |
Re: Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol 2021;4:927–42
|
Chiang, Cho-Han
|
|
|
5 |
2 |
p. 263-264
|
artikel
|
| 18 |
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press
|
Capitanio, Umberto
|
|
|
5 |
2 |
p. 261-262
|
artikel
|
| 19 |
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
|
Ratti, Maria Monica
|
|
|
5 |
2 |
p. 153-163
|
artikel
|
| 20 |
The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials
|
Sari Motlagh, Reza
|
|
|
5 |
2 |
p. 138-145
|
artikel
|
| 21 |
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
|
Gerdtsson, Axel
|
|
|
5 |
2 |
p. 235-243
|
artikel
|
| 22 |
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study
|
Ahdoot, Michael
|
|
|
5 |
2 |
p. 176-186
|
artikel
|
Tijdschrift beschrijving